Device Sectors
Damon Runyon Cancer Research Foundation awards $3.1M to 8 top young clinical investigators
July 1, 2010 9:33 am | by EurekAlert | News | Comments(Damon Runyon Cancer Research Foundation) The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its April 2010 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career...
Sysmex America Announces Executive Leadership Changes
July 1, 2010 9:33 am | by Bio-Medicine.Org | News | CommentsMUNDELEIN, Ill. , July 1 /- Sysmex America Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announces executive changes in the areas of corporate affairs, operations and technical services. John Kershaw, President & CEO, Sysmex...
Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets
July 1, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J. , July 1 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX ) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia 's CRINONE®...
Watson Launches Generic Exelon®
July 1, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J. , July 1 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has...
Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elekta's Leksell Gamma Knife Perfexion
July 1, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsATLANTA , July 1 /- The refinements in Elekta's Gamma Knife ® surgery technology that created the fifth generation Leksell Gamma Knife® Perfexion™ are radically changing the approach to treating brain metastases and other brain disorders. With Perfexion, physicians are...
NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
July 1, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 1 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China , today announced that it has appointed Roberto Bolli , M.D., to its Scientific Advisory Board....
FUISZ Announces Advances in Devices and Solid Dosage Form
July 1, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsMIAMI , July 1 /- FUISZ today announced two medical technology advances. First, FUISZ announced that it has received a notice of issuance from the United States Patent and Trademark Office for patent claims that cover a direct connection between prescribing physicians and blood analysis...
Par Pharmaceutical Begins Shipment of Generic Zegerid®
July 1, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsWOODCLIFF LAKE, N.J. , July 1 /- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it began shipping the 20mg/1100mg and 40mg/1100mg strengths of omeprazole and sodium bicarbonate capsules to the trade. Omeprazole and sodium bicarbonate capsules are the generic version...
FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP
July 1, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsSCHAUMBURG, Ill. , July 1 /- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's nine presentations of heparin sodium injection, USP. Heparin is a vital anticoagulant,...
Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology
July 1, 2010 5:33 am | by IBM | News | CommentsYORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently. Focused on...
Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTAâ„¢ for Men With Low Testosterone
July 1, 2010 12:33 am | by Bio-Medicine.Org | News | CommentsCHADDS FORD, Pa. , July 1 /- Endo Pharmaceuticals (Nasdaq: ENDP ) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for...
Stem-cell therapy may provide new approach to fight infection
June 30, 2010 10:33 pm | by EurekAlert | News | Comments(Ottawa Hospital Research Institute) A new study shows that treatment with mesenchymal stem cells can triple survival rates in mice with sepsis, a deadly condition that can occur when an infection spreads throughout the body. The treatment reduced the damaging effects of...
Planned home births associated with tripling of neonatal mortality rate vs. planned hospital births
June 30, 2010 10:33 pm | by EurekAlert | News | Comments(Elsevier Health Sciences) In a study published online today by the American Journal of Obstetrics & Gynecology, researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world. They report that less medical intervention,...
AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise
June 30, 2010 10:33 pm | by EurekAlert | News | Comments(American Academy of Otolaryngology -- Head and Neck Surgery) Today, the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) announced the release of a consensus statement to address ambiguities and disparities in the diagnosis and management of nasal valve compromise (NVC).
MicroBlasting Solution for Texturing Dental Implants
June 30, 2010 12:23 pm | Product Releases | CommentsComco Inc. has integrated the precision of micro-abrasive blasting with an advanced machining platform to create an ideal system for texturing dental implants. The Advanced Lathe LA3250 delivers a high degree of accuracy in its coordinated motion eliminating the need for masking.
Keeping weight down can decrease risk of arthritis
June 30, 2010 11:33 am | by Baylor College of Medicine | News | CommentsLosing weight reduces the risk of developing arthritis, especially in the knees.
Shire Purchases Strategic Site in Massachusetts
June 30, 2010 10:33 am | by Bio-Medicine.Org | News | CommentsLEXINGTON, Massachusetts , June 30, 2010 /- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced its purchase of the Lexington Technology Park campus in Lexington, Massachusetts . The purchase signifies an investment in the growth of its...
Positioner assembly tool for back and spinal surgery
June 30, 2010 10:26 am | by Par3 Technology | Articles | CommentsThe new design used to complete the surgery is named the Positioner Assembly Tool. The single tool design assembly includes details within the assembly which work with individual tools to complete all the necessary functions. During the product development process, Par3’s Analysis Driven Design Process was used to create features and functions to enhance and optimize the product. This process uses computer aided analysis software to optimize the design of a product and reduce the need for costly sample building and speed up the development cycle.
Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R & D Facilities Across the United States
June 30, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsBALTIMORE , June 30 /- GoIndustry DoveBid announces the Pfizer asset disposition program, which will see auctions of surplus assets from Pfizer's facilities across the United States . Over 500 lots per week will be available via online auction as part of GoIndustry DoveBid's ongoing...
Biospherics Acquires Global Patent Rights from University of Kentucky Research Foundation to Develop Tagatose as a Trigylcerides Therapy
June 30, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsBETHESDA, Md. , June 30 /- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies,...
AMS Receives 510(k) Clearance of Its Revolutionary MoXy(TM) Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
June 30, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsMINNETONKA, Minn. , June 30 /- American Medical Systems® (AMS) (Nasdaq: AMMD ), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the 510(k) clearance of its revolutionary MoXy™ Liquid Cooled Fiber. Designed to be...
New Leapfrog Report: A Call to Action on Improving the Safety of Computerized Prescribing Systems
June 30, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsLack of Testing and Monitoring By Hospitals and Vendors Potentially Jeopardizes Patients -- But Solutions Are Available WASHINGTON , June 30 /PRNewswire-USNewswire/ -- Health information technology could inadvertently result in harm to patients without proper monitoring, according to a...
OXIS International Assumes Control and Exploitation Rights to Key L-Ergothioneine Patent Filing Representing a Major Market Opportunity
June 30, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsBEVERLY HILLS, Calif. , June 30 /- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI), is extremely pleased to announce that it has assumed control and future exploitation rights to International Patent PCT Application PCY/US2008/059831. The invention centers on the use of...
Medolutions and COCSA Expand Relationship to Benefit the Chiropractic Profession
June 30, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsDUBLIN, Ohio , June 30 /- Medolutions, LLC, the manufacturer of the patented Bio-Back Lumbar Orthosis and the Congress of Chiropractic State Associations (COCSA) are pleased to announce that they have executed the COCSA Affinity Agreement. This agreement will introduce a new...
Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
June 30, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsCLEVELAND, Ohio , June 30, 2010 /- Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, and USF Health, an organization dedicated to creating a...
